Invention Grant
- Patent Title: Prodrugs of 2,4-pyrimidinediamine compounds and their uses
- Patent Title (中): 2,4-嘧啶二胺化合物的前药及其用途
-
Application No.: US14995027Application Date: 2016-01-13
-
Publication No.: US09532998B2Publication Date: 2017-01-03
- Inventor: Rajinder Singh , Somasekhar Bhamidipati , Esteban Masuda , Thomas Sun , Valentino J. Stella
- Applicant: Rajinder Singh , Somasekhar Bhamidipati , Esteban Masuda , Thomas Sun , Valentino J. Stella
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Agent Travis Young
- Main IPC: C07D498/04
- IPC: C07D498/04 ; A61K31/5383 ; A61K31/675 ; C07F9/6561 ; C07F9/6574 ; C07F9/6558
Abstract:
The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.
Public/Granted literature
- US20160136191A1 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses Public/Granted day:2016-05-19
Information query
